Extreme Prematurity

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Providence Therapeutics
1 program
Evaluating Decisional Regret Among MothersN/A1 trial
Active Trials
NCT04074525CompletedEst. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Providence TherapeuticsEvaluating Decisional Regret Among Mothers

Clinical Trials (1)

NCT04074525Providence TherapeuticsEvaluating Decisional Regret Among Mothers

Evaluating Decisional Regret Among Mothers

Start: Mar 2020Est. completion: Jun 2021
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space